Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/build metadata change rather than an alteration to the clinical trial content.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3 label.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1; this is a minor site maintenance update that does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check90 days agoChange DetectedA site-wide funding/status notice was added and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.